The recent trading activities of company executives often provide insight into internal confidence regarding a firm's valuation trajectory. In this context, Robert A. Bruggeworth, President and CEO of Qorvo, Inc., completed the sale of 57,957 shares of the company’s common stock on June 1, 2026. These transactions accounted for an approximate value of $5.82 million. The selling prices varied across a range, specifically between $99.73 and $102.4 per share.
It is important to note that these sales were executed under the framework of a Rule 10b5-1 trading plan, which Mr. Bruggeworth had initially adopted on February 25, 2026. Following the execution of this planned sale, Mr. Bruggeworth's direct holdings in Qorvo common stock amounted to 319,880 shares.
Separately, Qorvo Inc.'s recent financial reporting provided several key metrics for investors to consider. The company reported fourth-quarter results that managed to surpass the expectations set by Wall Street analysts. Specifically, Qorvo achieved adjusted earnings per share of $1.69. This figure exceeded the analyst consensus estimate of $1.21, representing a positive variance of $0.48.
Revenue figures also showed strong performance against estimates. Qorvo's total revenue reached $808.3 million, surpassing the projected estimate of $801.31 million. However, this figure represented a 7.0% decrease when compared to the company's revenue of $869.5 million from the previous year.
Another notable development was the improvement in Qorvo’s adjusted gross margin. This margin expanded to 52.6%, marking an increase of 670 basis points when measured year-over-year. CEO Bob Bruggeworth stated that this growth stemmed from "continued operational excellence and the strategic optimization of business mix." Looking at the full fiscal year for 2026, the adjusted gross margin showed a solid improvement of 370 basis points compared to the preceding fiscal year.
In terms of market valuation perception, external analysis suggests Qorvo might be trading below its intrinsic worth. According to an InvestingPro assessment, the company appears undervalued at current levels. Furthermore, multiple analysts have recently revised their earnings forecasts upwards for the upcoming period, with nine separate analysts making such revisions.
The stock has also demonstrated strong recent performance, trading near its 52-week high of $109.49 and achieving a substantial return of 30.9% over the past twelve months. These combined details paint a picture of a company focused on refining its operational processes and financial outcomes while navigating fluctuations in revenue.